your market intelligence analyst
Search Results
129 results
Your search is now limited to «Company News in Infectious Diseases» expert search.
Healio News 11/12/2019 15:46
Tedros Adhanom Ghebreyesus One day after winning conditional approval in Europe, Merck’s Ebola vaccine received prequalification status from WHO, giving it the agency’s stamp of approval as a safe and effective prevention tool against the deadly virus.
More from Healio News: 11/12/2019 10:31
According to Takeda, Clinical Phase 1 and 2 data in children and adolescents showed that TAK-003 induced immune responses against all four dengue serotypes, in both seropositive and seronegative participants, and the vaccine was found to be ...
More from
NASDAQ 11/12/2019 08:05
Apart from the Ebola vaccine candidate, Merck is studying an investigational 15-valent pneumococcal conjugate vaccine candidate, V114, in late-stage studies.
More from NASDAQ:
PMLiVE 11/12/2019 07:34
The approval comes shortly after Johnson & Johnson filed its Ebola vaccine candidate (Ad26.ZEBOV, MVA-BN-Filo) with the EMA, setting up a possible approval next year, and ahead of a potential approval of Ervebo in the US due next March.
More from PMLiVE:
FiercePharmaManufacturing 11/11/2019 15:02
RELATED: Merck's experimental Ebola shot gets set to fight deadly new outbreak in Congo That R&D work eventually led to Merck’s Ebola shot.
More from FiercePharmaManufacturing:
Business Wire 11/11/2019 15:00
Merck’s Commitment to Infectious Diseases For more than 100 years, Merck has contributed to the discovery and development of novel medicines and vaccines to combat infectious diseases.
More from Business Wire:
Takeda’s dengue vaccine candidate demonstrates protection in children ages four to 16 years.
More from Pharmaceutical Business Review:
BioPharma-Reporter 11/07/2019 12:38
Johnson & Johnson made the announcement that, alongside partner Bavarian Nordic, it had submitted marketing authorization applications (MAAs) to the European Medicines Agency (EMA) for the companies’ two-dose vaccine regimen.
More from BioPharma-Reporter:
Johnson & Johnson 11/07/2019 10:05
About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.
More from Johnson & Johnson:
ETHealthWorld (India) 11/07/2019 07:10
Johnson & Johnson said on Thursday it had filed for an approval from European regulators for its two-dose experimental vaccine to protect against Ebola , less than a month after the agency recommended approval of Merck & Co Inc's ...
More from ETHealthWorld (India):
Channel NewsAsia (Singapore) 11/07/2019 06:28
Last month, Merck & Co's Ebola vaccine was recommended for approval by the EMA, in a move hailed by the World Health Organization as a "triumph for public health" that could save many lives.
More from Channel NewsAsia (Singapore):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications